NASDAQ
Envoy Medical, Inc. (COCH) has a price/sales ratio of 53.77x as of Friday, May 22, 2026. This represents a 77.11% decrease compared to its 12-month average of 234.92x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.